These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12704346)

  • 1. IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy.
    Binstadt BA; Geha RS; Bonilla FA
    J Allergy Clin Immunol; 2003 Apr; 111(4):697-703. PubMed ID: 12704346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Fc receptors: critical targets in the treatment of autoimmune diseases and transplant rejections.
    Ivan E; Colovai AI
    Hum Immunol; 2006 Jul; 67(7):479-91. PubMed ID: 16829303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG receptor polymorphisms: risk factors for disease.
    van der Pol W; van de Winkel JG
    Immunogenetics; 1998 Aug; 48(3):222-32. PubMed ID: 9683667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of Fc gamma receptor polymorphisms.
    Rascu A; Repp R; Westerdaal NA; Kalden JR; van de Winkel JG
    Ann N Y Acad Sci; 1997 Apr; 815():282-95. PubMed ID: 9186665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of the association between low-affinity Fcgamma receptor gene polymorphisms and hematologic and autoimmune disease.
    Trikalinos TA; Karassa FB; Ioannidis JP
    Blood; 2001 Sep; 98(5):1634-5. PubMed ID: 11547773
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombopoietin receptor agonist, splenectomy and intravenous immunoglobulin for immune thrombocytopaenia with systemic lupus erythematosus.
    Sofue H; Kida T; Seno T; Kohno M; Kawahito Y
    Rheumatology (Oxford); 2018 Aug; 57(8):1495-1497. PubMed ID: 29579273
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 8. Fc receptors for immunoglobulin G--a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Myhr KM; Nyland H
    J Neuroimmunol; 2001 Aug; 118(2):187-93. PubMed ID: 11498253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune regulation by Fc receptors].
    Takai T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():420-7. PubMed ID: 15861691
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
    Crow AR; Lazarus AH
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S14-8. PubMed ID: 14668633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.
    Ronda N; Hurez V; Kazatchkine MD
    Vox Sang; 1993; 64(2):65-72. PubMed ID: 8456559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology. Giving inhibitory receptors a boost.
    Lin SY; Kinet JP
    Science; 2001 Jan; 291(5503):445-6. PubMed ID: 11228143
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome.
    Vedeler CA; Raknes G; Myhr KM; Nyland H
    Neurology; 2000 Sep; 55(5):705-7. PubMed ID: 10980740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.
    Smith KG; Clatworthy MR
    Nat Rev Immunol; 2010 May; 10(5):328-43. PubMed ID: 20414206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fc receptor blockade in patients with chronic refractory autoimmune thrombocytopenia].
    Ruiz-Argüelles GJ; Ruiz-Argüelles A; Marín-López A
    Rev Invest Clin; 1993; 45(2):182-3. PubMed ID: 8393212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.